Sitero Acquires Axiom Real-Time Metrics, Expanding Global Footprint and Strengthening Technology-Enabled Full-Service Clinical Services

Miami, FL — July 15, 2025 — Sitero, a leading provider of clinical services and technology, today announced that it has acquired Axiom Real-Time Metrics, a recognized innovator in eClinical solutions and full-service global clinical operations.

This strategic transaction marks a significant milestone for both organizations and underscores a shared commitment to delivering flexible, efficient, and technology-enabled services to the global life sciences community. Since its founding in 2001, Axiom has supported hundreds of global clinical trials spanning Phase I to Phase IV across device, pharmaceutical, and biotech sectors.

The combination of Sitero and Axiom will bring together two organizations with highly aligned missions: to accelerate clinical development through unified, tech-enabled solutions tailored to the evolving needs of sponsors. By integrating Axiom’s proprietary eClinical platform and deep data and operations expertise, Sitero continues to disrupt traditional clinical development processes through its comprehensive technology and clinical operations support.

“We’re thrilled to welcome Axiom to the Sitero family,” said Sankesh Abbhi, CEO of Sitero. “Axiom has built a strong reputation not only for its innovative, technology-forward solutions, but also for its deep expertise in delivering full-service clinical operations with a customer-first approach for hundreds of trials. Together, we are creating a more powerful, end-to-end clinical services platform—enabled by advanced technology—that ensures continuity for existing clients while expanding our ability to support trials globally with greater flexibility, scale, and operational excellence.”

Sitero’s investment in advanced technology, data-driven infrastructure, and process innovation complements Axiom’s capabilities in eClinical software and full-service clinical delivery. Clients from both organizations will benefit from an expanded global presence and enhanced service offerings.

“This transaction represents a strong step forward for Axiom’s clients, employees, and partners,” said Wayne Weaver, CEO of Axiom. “Sitero’s focus on innovation and operational excellence aligns perfectly with our mission. Together, we will bring even greater value to our customers and accelerate smarter, faster clinical development worldwide.”

The acquisition will also advance the integration of AI-driven capabilities into Sitero’s proprietary Mentor eClinical suite. Leveraging Axiom’s proven platform and Sitero’s ongoing AI investments, the combined organization is positioned to drive significant efficiency gains, improve trial oversight, and reduce development timelines across clinical programs.